MEDS · DataMeds AI Inc. Common Stock
View on chartInsiders & Stakes
| Brian Norton Chief Executive Officer | ▲ Buy | Grant | 9,044,720 Shares held | 3/21/2025 | View profile |
| Prashant Patel Chief Strategy Officer | ▼ Sell | Other | 282,365 Shares held | 6/22/2026 | View profile |
| Surendra K. Ajjarapu Director | ▼ Sell | Other | 257,645 Shares held | 6/22/2026 | View profile |
| Sajid Syed Director | ▲ Buy | Grant | 244,720 Shares held | 3/21/2025 | View profile |
| Donald William Anderson Director | ▲ Buy | Grant | 244,720 Shares held | 3/21/2025 | View profile |
| Rebecca M. Shanahan Director | ▲ Buy | Grant | 244,720 Shares held | 3/21/2025 | View profile |
| Michael L. Peterson Director | ▲ Buy | Grant | 200,000 Shares held | 7/2/2025 | View profile |
| Shafaat Pirani Chief Clinical Officer | ▲ Buy | Grant | 102,080 Shares held | 3/21/2025 | View profile |
| Nikul Panchal Chief Pharmacy Officer | ▲ Buy | Grant | 90,000 Shares held | 3/21/2025 | View profile |
Transaction History
| Surendra K. Ajjarapu | ▼ Sell | Other | 100,000 | $500 | 6/22/2026 |
| Prashant Patel | ▼ Sell | Other | 100,000 | $500 | 6/22/2026 |
| Prashant Patel | ▲ Buy | Grant | 5,000,000 | $1.0M | 3/31/2026 |
| Surendra K. Ajjarapu | ▲ Buy | Grant | 5,000,000 | $1.0M | 3/31/2026 |
| Michael L. Peterson | ▲ Buy | Grant | 200,000 | $180K | 7/2/2025 |
| Shafaat Pirani | ▲ Buy | Grant | 35,000 | $0 | 3/21/2025 |
| Sajid Syed | ▲ Buy | Grant | 200,000 | $0 | 3/21/2025 |
| Surendra K. Ajjarapu | ▲ Buy | Grant | 2,882,247 | $0 | 3/21/2025 |
| Surendra K. Ajjarapu | ▲ Buy | Grant | 600,000 | $0 | 3/21/2025 |
| Surendra K. Ajjarapu | ▲ Buy | Grant | 600,000 | $0 | 3/21/2025 |
| Prashant Patel | ▲ Buy | Grant | 1,882,247 | $0 | 3/21/2025 |
| Prashant Patel | ▲ Buy | Grant | 1,500,000 | $0 | 3/21/2025 |
| Prashant Patel | ▲ Buy | Grant | 700,000 | $0 | 3/21/2025 |
| Donald William Anderson | ▲ Buy | Grant | 200,000 | $0 | 3/21/2025 |
| Brian Norton | ▲ Buy | Grant | 9,000,000 | $0 | 3/21/2025 |
| Nikul Panchal | ▲ Buy | Grant | 90,000 | $0 | 3/21/2025 |
| Rebecca M. Shanahan | ▲ Buy | Grant | 200,000 | $0 | 3/21/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MEDS hits $1M monthly Corexa revenue, unveils health app
DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.
MEDS hits $1M monthly Corexa revenue, unveils health app. DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.